Year: 2021
Type: article
Study design: Observational Study
DOI: 10.1111/jth.15534
Authors: Tessa J. Barrett, Seda Bilaloglu, Macintosh Cornwell, Hannah M. Burgess, Vitor W. Virginio, Kamelia Drenkova, Homam Ibrahim, Eugene Yuriditsky, Yin Aphinyanaphongs, Mark Lifshitz, Feng Xia Liang, Julie Alejo, Grace Smith, Stefania Pittaluga, Amy V. Rapkiewicz, Jun Wang, Camelia Iancu‐Rubin, Ian Mohr, Kelly Ruggles, Kenneth A. Stapleford, Judith Hochman, Jeffrey S. Berger
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Heart Association, American Society of Hematology, Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences
Awards: G1734361364, G1859754121, ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center, Clinical and Translational Science Award, G3084026282, G3761063458, G427751140, Control of Translation in Herpesvirus Infected Cells - Resubmission - 1, G5393666985, Virus Host Interactions that Regulate Translation in Cells Infected with HSV-1, G7859503857, G9000028856, G9000053352, G9000240877, EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION, G903119666, G935675016
OpenAlex ID: W3201328882